Stuart A Arbuckle insider trades
Open-market stock purchases and sales by Stuart A Arbuckle, Director at Rhythm Pharmaceuticals, Inc, from SEC Form 4 filings since Sep 4, 2012.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Jun 24, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 24, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 23, 2026 | RYTM Rhythm Pharmaceuticals, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Jun 10, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| May 20, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 6, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Feb 6, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Feb 6, 2026 | PRAX Praxis Precision Medicines, Inc | Bought (not open market) | — |
| Jan 5, 2026 | ALNY Alnylam Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- RYTM Rhythm Pharmaceuticals, Inc: other filings, last Jun 24, 2026
- PRAX Praxis Precision Medicines, Inc: other filings, last Jun 10, 2026
- ALNY Alnylam Pharmaceuticals, Inc: other filings, last May 20, 2026
- VRTX Vertex Pharmaceuticals Inc / MA: 252 sales, last Jul 1, 2025
- IMGN ImmunoGen, Inc: other filings, last Feb 12, 2024
- CERU Cerulean Pharma Inc: other filings, last Jan 3, 2017